Cargando…

The role of DNA mismatch repair in immunotherapy of human cancer

DNA mismatch repair (MMR) is an important pathway which helps to maintain genomic stability. Mutations in DNA MMR genes are found to promote cancer initiation and foster tumor progression. Deficiency or inactivation of MMR results in microsatellite instability (MSI) which triggers neoantigen generat...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yuchen, Zhang, Luyuan, Zhou, Ruoyu, Wang, Yumin, Chen, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066103/ https://www.ncbi.nlm.nih.gov/pubmed/35541922 http://dx.doi.org/10.7150/ijbs.71714

Ejemplares similares

DNA mismatch repair in cancer immunotherapy
por: Guan, Junhong, et al.
Publicado: (2023)

Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
por: Zhang, Cong-Min, et al.
Publicado: (2016)

DNA Mismatch Repair and its Role in Huntington’s Disease
por: Iyer, Ravi R., et al.
Publicado: (2021)

Role of APC and DNA mismatch repair genes in the development of colorectal cancers
por: Narayan, Satya, et al.
Publicado: (2003)

Role of mismatch repair in aging
por: Wen, Jie, et al.
Publicado: (2021)

DNA mismatch repair in the context of chromatin
por: Huang, Yaping, et al.
Publicado: (2020)

Vaccines for immunoprevention of DNA mismatch repair deficient cancers
por: Hernandez-Sanchez, Alejandro, et al.
Publicado: (2022)

DNA mismatch repair gene mutations in human cancer.
por: Peltomäki, P
Publicado: (1997)

DNA Mismatch Repair in Eukaryotes and Bacteria
por: Fukui, Kenji
Publicado: (2010)

Human DNA mismatch repair: coupling of mismatch recognition to strand-specific excision
por: Wang, Huixian, et al.
Publicado: (2007)

Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
por: Viale, Giulia, et al.
Publicado: (2017)

DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers
por: Caja, Fabian, et al.
Publicado: (2020)

DNA Mismatch Repair and Oxidative DNA Damage: Implications for Cancer Biology and Treatment
por: Bridge, Gemma, et al.
Publicado: (2014)

Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer
por: Masuda, Kenta, et al.
Publicado: (2011)

Role of DNA repair defects in predicting immunotherapy response
por: Zhang, Jing, et al.
Publicado: (2020)

Fluorescence detection of DNA mismatch repair in human cells
por: Ito, Shunsuke, et al.
Publicado: (2018)

The correlation between DNA mismatch repair status and the clinicopathological and molecular features of Chinese sporadic colorectal cancer
por: Li, Cong, et al.
Publicado: (2020)

The Mismatch Repair System (MMR) in Head and Neck Carcinogenesis and Its Role in Modulating the Response to Immunotherapy: A Critical Review
por: Cilona, Maria, et al.
Publicado: (2020)

Loss of DNA mismatch repair proteins in prostate cancer
por: Sharma, Meenal, et al.
Publicado: (2020)

Progress of Gastric Cancer Surgery in the era of Precision Medicine
por: Wang, Yumin, et al.
Publicado: (2021)

Pediatric Rectal Adenocarcinoma With Mismatch Repair Deficiency Responds to Immunotherapy
por: Qureshi, Naveen, et al.
Publicado: (2023)

Immune escape and resistance to immunotherapy in mismatch repair deficient tumors
por: Mestrallet, Guillaume, et al.
Publicado: (2023)

The Startling Role of Mismatch Repair in Trinucleotide Repeat Expansions
por: Richard, Guy-Franck
Publicado: (2021)

Mismatch Repair Screening of Gastrointestinal Cancers: The Impact on Lynch Syndrome Detection and Immunotherapy
por: R., Openshaw M., et al.
Publicado: (2022)

Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?
por: Huyghe, Nicolas, et al.
Publicado: (2019)

Mutational signatures of DNA mismatch repair deficiency in C. elegans and human cancers
por: Meier, Bettina, et al.
Publicado: (2018)

Advances of DNA Damage Repair-Related Drugs and Combination With Immunotherapy in Tumor Treatment
por: Wang, Yumin, et al.
Publicado: (2022)

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer
por: Sena, Laura A., et al.
Publicado: (2020)

Expression of human DNA mismatch-repair protein, hMSH2, in patients with oral lichen planus
por: LI, HAO-BO, et al.
Publicado: (2015)

Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2015)

Regulation of DNA damage responses by mismatch repair
por: Zhitkovich, Anatoly
Publicado: (2010)

Correction to: DNA mismatch repair in the context of chromatin
por: Huang, Yaping, et al.
Publicado: (2020)

Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer
por: He, Yinjun, et al.
Publicado: (2023)

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
por: Wensink, G. Emerens, et al.
Publicado: (2020)

Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma
por: Ebia, Matthew I., et al.
Publicado: (2023)

DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers
por: Mas-Ponte, David, et al.
Publicado: (2020)

DNA Mismatch Repair System: Repercussions in Cellular Homeostasis and Relationship with Aging
por: Conde-Pérezprina, Juan Cristóbal, et al.
Publicado: (2012)

Computed Tomography Features of Gastric Cancer Patients With DNA Mismatch Repair Deficiency
por: Cao, Qian, et al.
Publicado: (2021)

Stability across the Whole Nuclear Genome in the Presence and Absence of DNA Mismatch Repair
por: Lujan, Scott Alexander, et al.
Publicado: (2021)

Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy
por: Yu, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_11t7s6ijpr28hbmq0ahjalv783